Latest Stories
Don’t miss our hot and upcoming stories
Insilico Medicine Achieves Milestone with Positive Phase I Results for AI-Designed IBD Drug ISM5411
CAMBRIDGE, Massachusetts, January 7, 2024 Insilico Medicine, a clinical-stage leader in generative AI-driven drug discovery…
Bristol Myers Squibb Taps AI-Driven Discovery with Terray Therapeutics to Accelerate Small Molecule Drug Development
Los Angeles – Dec 14, 2023 Terray Therapeutics, a leader in AI-driven small molecule discovery,…
PostEra and Amgen Forge AI Drug Discovery Partnership Worth Over $1 Billion
Boston – Nov 16, 2023 Advancing Small Molecule Therapeutics with AI PostEra has entered into…
NVIDIA Backs Terray Therapeutics to Advance Generative AI for Small Molecule Drug Discovery
Los Angeles – Nov 9, 2023 Terray Therapeutics, a biotechnology company pioneering AI-driven small molecule…





